These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 32373212)

  • 1. Endothelial to mesenchymal transition contributes to nicotine-induced atherosclerosis.
    Qin W; Zhang L; Li Z; Xiao D; Zhang Y; Zhang H; Mokembo JN; Monayo SM; Jha NK; Kopylov P; Shchekochikhin D; Zhang Y
    Theranostics; 2020; 10(12):5276-5289. PubMed ID: 32373212
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of miR-122 reduced atherosclerotic lesion formation by regulating NPAS3-mediated endothelial to mesenchymal transition.
    Wu X; Du X; Yang Y; Liu X; Liu X; Zhang N; Li Y; Jiang X; Jiang Y; Yang Z
    Life Sci; 2021 Jan; 265():118816. PubMed ID: 33278397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotine Accelerates Atherosclerosis in Apolipoprotein E-Deficient Mice by Activating α7 Nicotinic Acetylcholine Receptor on Mast Cells.
    Wang C; Chen H; Zhu W; Xu Y; Liu M; Zhu L; Yang F; Zhang L; Liu X; Zhong Z; Zhao J; Jiang J; Xiang M; Yu H; Hu X; Lu H; Wang J
    Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):53-65. PubMed ID: 27834689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial to mesenchymal transition is common in atherosclerotic lesions and is associated with plaque instability.
    Evrard SM; Lecce L; Michelis KC; Nomura-Kitabayashi A; Pandey G; Purushothaman KR; d'Escamard V; Li JR; Hadri L; Fujitani K; Moreno PR; Benard L; Rimmele P; Cohain A; Mecham B; Randolph GJ; Nabel EG; Hajjar R; Fuster V; Boehm M; Kovacic JC
    Nat Commun; 2016 Jun; 7():11853. PubMed ID: 27340017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD163
    Mori M; Sakamoto A; Kawakami R; Guo L; Slenders L; Mosquera JV; Ghosh SKB; Wesseling M; Shiraki T; Bellissard A; Shah P; Weinkauf CC; Konishi T; Sato Y; Cornelissen A; Kawai K; Jinnouchi H; Xu W; Vozenilek AE; Williams D; Tanaka T; Sekimoto T; Kelly MC; Fernandez R; Grogan A; Coslet AJ; Fedotova A; Kurse A; Mokry M; Romero ME; Kolodgie FD; Pasterkamp G; Miller CL; Virmani R; Finn AV
    Circ Res; 2024 Jul; 135(2):e4-e23. PubMed ID: 38860377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HDAC3 inhibitor suppresses endothelial-to-mesenchymal transition via modulating inflammatory response in atherosclerosis.
    Chen L; Shang C; Wang B; Wang G; Jin Z; Yao F; Yue Z; Bai L; Wang R; Zhao S; Liu E; Wang W
    Biochem Pharmacol; 2021 Oct; 192():114716. PubMed ID: 34339713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidized low density lipoprotein induces endothelial-to-mesenchymal transition by stabilizing Snail in human aortic endothelial cells.
    Su Q; Sun Y; Ye Z; Yang H; Li L
    Biomed Pharmacother; 2018 Oct; 106():1720-1726. PubMed ID: 30119247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine promotes atherosclerosis via ROS-NLRP3-mediated endothelial cell pyroptosis.
    Wu X; Zhang H; Qi W; Zhang Y; Li J; Li Z; Lin Y; Bai X; Liu X; Chen X; Yang H; Xu C; Zhang Y; Yang B
    Cell Death Dis; 2018 Feb; 9(2):171. PubMed ID: 29416034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone deacetylase 9 promotes endothelial-mesenchymal transition and an unfavorable atherosclerotic plaque phenotype.
    Lecce L; Xu Y; V'Gangula B; Chandel N; Pothula V; Caudrillier A; Santini MP; d'Escamard V; Ceholski DK; Gorski PA; Ma L; Koplev S; Bjørklund MM; Björkegren JL; Boehm M; Bentzon JF; Fuster V; Kim HW; Weintraub NL; Baker AH; Bernstein E; Kovacic JC
    J Clin Invest; 2021 Aug; 131(15):. PubMed ID: 34338228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High glucose mediates endothelial-to-chondrocyte transition in human aortic endothelial cells.
    Tang R; Gao M; Wu M; Liu H; Zhang X; Liu B
    Cardiovasc Diabetol; 2012 Sep; 11():113. PubMed ID: 22998723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial-to-Mesenchymal Transition Contributes to Accelerated Atherosclerosis in Hutchinson-Gilford Progeria Syndrome.
    Hamczyk MR; Nevado RM; Gonzalo P; Andrés-Manzano MJ; Nogales P; Quesada V; Rosado A; Torroja C; Sánchez-Cabo F; Dopazo A; Bentzon JF; López-Otín C; Andrés V
    Circulation; 2024 Nov; 150(20):1612-1630. PubMed ID: 39206565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of α7nAChR enhances endothelial-to-mesenchymal transition after myocardial infarction via NF-κB activation.
    Li X; Zhu X; Li B; Xia B; Tang H; Hu J; Ying R
    Exp Cell Res; 2022 Oct; 419(1):113300. PubMed ID: 35926661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shear stress induces endothelial-to-mesenchymal transition via the transcription factor Snail.
    Mahmoud MM; Serbanovic-Canic J; Feng S; Souilhol C; Xing R; Hsiao S; Mammoto A; Chen J; Ariaans M; Francis SE; Van der Heiden K; Ridger V; Evans PC
    Sci Rep; 2017 Jun; 7(1):3375. PubMed ID: 28611395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of endothelial adenosine receptor 2 A suppresses atherosclerosis in vivo through inhibiting CREB-ALK5-mediated endothelial to mesenchymal transition.
    Cai Y; Zhou Y; Yang Q; Xu J; Da Q; Ma Q; Zhao D; Lu T; Kim HW; Fulton D; Jiang X; Weintraub NL; Dong K; Xu S; Hong M; Liu Z; Huo Y
    Pharmacol Res; 2024 May; 203():107156. PubMed ID: 38522762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial-to-mesenchymal transition shapes the atherosclerotic plaque and modulates macrophage function.
    Helmke A; Casper J; Nordlohne J; David S; Haller H; Zeisberg EM; von Vietinghoff S
    FASEB J; 2019 Feb; 33(2):2278-2289. PubMed ID: 30260706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrogen sulfide attenuates atherosclerosis induced by low shear stress by sulfhydrylating endothelium NFIL3 to restrain MEST mediated endothelial mesenchymal transformation.
    Zhou K; Luo W; Gui DD; Ren Z; Wei DH; Liu LS; Li GH; Tang ZH; Xiong WH; Hu HJ; Jiang ZS
    Nitric Oxide; 2024 Jan; 142():47-57. PubMed ID: 38049061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tenascin-X Mediates Flow-Induced Suppression of EndMT and Atherosclerosis.
    Liang G; Wang S; Shao J; Jin YJ; Xu L; Yan Y; Günther S; Wang L; Offermanns S
    Circ Res; 2022 May; 130(11):1647-1659. PubMed ID: 35443807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of CLOCK under high glucose upregulates ROCK1-mediated endothelial to mesenchymal transition and aggravates plaque vulnerability.
    Tang H; Zhu M; Zhao G; Fu W; Shi Z; Ding Y; Tang X; Guo D
    Atherosclerosis; 2018 Aug; 275():58-67. PubMed ID: 29860109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trimethylamine N-oxide promotes PERK-mediated endothelial-mesenchymal transition and apoptosis thereby aggravates atherosclerosis.
    Bingyu W; Jun Q; Bingyang L; Xi Y; Jianqing Z; Jiangfang L
    Int Immunopharmacol; 2024 Dec; 142(Pt B):113209. PubMed ID: 39340998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial-to-mesenchymal transition contributes to fibro-proliferative vascular disease and is modulated by fluid shear stress.
    Moonen JR; Lee ES; Schmidt M; Maleszewska M; Koerts JA; Brouwer LA; van Kooten TG; van Luyn MJ; Zeebregts CJ; Krenning G; Harmsen MC
    Cardiovasc Res; 2015 Dec; 108(3):377-86. PubMed ID: 26084310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.